An expression of concern on: Grb2 induces cardiorenal syndrome type 3: Roles of IL-6, cardiomyocyte bioenergetics, and Akt/mTOR pathway
Frontiers Editorial Office*An Expression of Concern on
An expression of concern on: Grb2inducescardiorenalsyndrometype 3:roles of IL-6, cardiomyocytebioenergetics, and Akt/mTORpathway
by Wang, J., Sun, X., Wang, X., Cui, S., Liu, R., Liu, J., Fu, B., Gong, M., Wang, C., Shi, Y., Chen, Q., Cai, G., and Chen, X. (2021). Front. Cell Dev. Biol. 9:630412. doi: 10.3389/fcell.2021.630412
Following publication, the publisher has uncovered conclusive evidence that a false identity was used as a peer reviewer for this article. This reviewer was not suggested by the authors. This peer reviewer has now been removed.
This article is currently under post publication assessment. This expression of concern has been posted while Frontiers awaits the outcome of this assessment and will then be updated accordingly.
Citation: (2022) An expression of concern on: Grb2 induces cardiorenal syndrome type 3: Roles of IL-6, cardiomyocyte bioenergetics, and Akt/mTOR pathway. Front. Cell Dev. Biol. 10:1014332. doi: 10.3389/fcell.2022.1014332
Received: 08 August 2022; Accepted: 08 August 2022;
Published: 17 August 2022.
Approved by:
Frontiers Editorial OfficeCopyright © 2022 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, editorial.office@frontiersin.org